Charlene E Reimnitz, MD

Offices

1 location

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Reimnitz’s office at (408) 356-0431 to ask if they take your plan before you enroll.

California Medical Board record

Licence A42240 · Current

Licensed to practise in California · since 1985 · expires 2027-06-30 · Case Western Reserve University School of Medicine.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

School, training and certification

What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.

Specialty certification

American Board of Obstetrics and Gynecology - Obstetrics and Gynecology

Drugs they prescribed that Part D paid

$2,988

Pharmacies billed $2,988 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 37) in 2024. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.

33 generic and fewer than 11 brand-name prescriptions · $2,988 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Year by year

Sort by

Part D prescribing by year

2024	37	18	0% (0)	None	$2,988
2023	169	60	0% (0)	20%	$27,941
2022	235	87	0% (0)	19%	$33,965
2021	371	117	None	19%	$49,568
2020	350	109	0% (0)	21%	$49,997
2019	420	136	None	23%	$59,764
2018	396	128	None	27%	$61,644
2017	474	132	None	34%	$78,090
2016	515	137	None	40%	$73,424
2015	479	128	None	35%	$56,979
2014	487	113	None	38%	$53,776
2013	413	94	None	41%	$39,784

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 4 drugs

Sort by

Part D drugs prescribed in 2023

Estradiol	39	$4,477	$115
Yuvafem	15	$3,422	$228
Valacyclovir	11	$970	$88
Alendronate	19	$218	$11

2022: 5 drugs

Sort by

Part D drugs prescribed in 2022

Premarin	21	$9,493	$452
Estradiol	43	$3,278	$76
Yuvafem	11	$2,528	$230
Valacyclovir	13	$1,775	$137
Alendronate	30	$247	$8

2021: 9 drugs

Sort by

Part D drugs prescribed in 2021

Premarin	27	$11,729	$434
Estring	13	$6,728	$518
Yuvafem	19	$4,071	$214
Estradiol	52	$3,749	$72
Valacyclovir	16	$2,121	$133
Progesterone	25	$1,859	$74
Nitrofurantoin Mono-Macro	13	$725	$56
Medroxyprogesterone Acetate	17	$332	$20
Alendronate	17	$174	$10

2020: 10 drugs

Sort by

Part D drugs prescribed in 2020

Estring	22	$10,902	$496
Premarin	22	$9,474	$431
Estradiol	64	$5,960	$93
Yuvafem	15	$3,360	$224
Valacyclovir	17	$1,778	$105
Progesterone	20	$1,739	$87
Clotrimazole-Betamethasone	15	$371	$25
Medroxyprogesterone Acetate	18	$303	$17
Acyclovir	13	$178	$14
Fluconazole	12	$162	$14

2019: 10 drugs

Sort by

Part D drugs prescribed in 2019

Estradiol	106	$13,835	$131
Premarin	25	$10,380	$415
Estring	13	$6,158	$474
Yuvafem	21	$2,873	$137
Progesterone	23	$2,046	$89
Valacyclovir	12	$1,001	$83
Ibandronate	13	$802	$62
Nitrofurantoin Mono-Macro	13	$569	$44
Clotrimazole-Betamethasone	12	$386	$32
Medroxyprogesterone Acetate	17	$209	$12

2018: 8 drugs

Sort by

Part D drugs prescribed in 2018

Premarin	22	$8,623	$392
Estring	20	$8,494	$425
Yuvafem	41	$8,260	$201
Estradiol	91	$6,824	$75
Estrace	12	$3,795	$316
Progesterone	22	$2,409	$109
Levothyroxine	13	$248	$19
Medroxyprogesterone Acetate	14	$131	$9

2017: 12 drugs

Sort by

Part D drugs prescribed in 2017

Vagifem	36	$14,847	$412
Premarin	36	$12,931	$359
Estring	18	$6,799	$378
Estrace	15	$6,245	$416
Yuvafem	11	$5,809	$528
Estradiol	105	$5,115	$49
Progesterone	21	$2,613	$124
Zolpidem	29	$560	$19
Nitrofurantoin Mono-Macro	11	$465	$42
Clotrimazole-Betamethasone	11	$279	$25
Medroxyprogesterone Acetate	18	$258	$14
Alendronate	14	$123	$9

2016: 14 drugs

Sort by

Part D drugs prescribed in 2016

Premarin	55	$16,715	$304
Vagifem	49	$15,950	$326
Estring	18	$5,475	$304
Estrace	13	$3,422	$263
Estradiol	77	$2,960	$38
Progesterone	21	$2,188	$104
Raloxifene	13	$1,944	$150
Zolpidem	20	$496	$25
Nitrofurantoin Mono-Macro	11	$478	$43
Clotrimazole-Betamethasone	12	$455	$38
Levothyroxine	15	$304	$20
Alendronate	20	$234	$12
Medroxyprogesterone Acetate	17	$148	$9
Acyclovir	11	$116	$11

2015: 11 drugs

Sort by

Part D drugs prescribed in 2015

Premarin	40	$10,999	$275
Vagifem	38	$9,970	$262
Estring	18	$4,669	$259
Estrace	17	$4,626	$272
Estradiol	67	$2,175	$32
Progesterone	15	$1,953	$130
Clotrimazole-Betamethasone	21	$936	$45
Zolpidem	33	$532	$16
Alendronate	23	$313	$14
Fluconazole	28	$176	$6
Medroxyprogesterone Acetate	13	$91	$7

2014: 14 drugs

Sort by

Part D drugs prescribed in 2014

Vagifem	55	$8,759	$159
Vesicare	14	$6,112	$437
Raloxifene	13	$5,748	$442
Premarin	29	$5,536	$191
Vivelle-Dot	22	$3,430	$156
Estrace	20	$3,241	$162
Estring	14	$3,137	$224
Progesterone	14	$1,969	$141
Estradiol	70	$1,225	$17
Zolpidem	41	$314	$8
Alendronate	13	$254	$20
Medroxyprogesterone Acetate	16	$127	$8
Fluconazole	12	$96	$8
Fluoxetine	15	$74	$5

2013: 9 drugs

Sort by

Part D drugs prescribed in 2013

Vagifem	61	$7,747	$127
Premarin	26	$5,226	$201
Detrol La	19	$5,108	$269
Vivelle-Dot	15	$2,815	$188
Estrace	14	$2,234	$160
Ibandronate	11	$1,303	$118
Estradiol	86	$1,296	$15
Zolpidem	39	$267	$7
Medroxyprogesterone Acetate	17	$203	$12

Money from drug and device companies

$25 in 2024

Sort by

Industry payments by year

2024	1	1	None	$25
2021	1	1	None	$22
2020	1	4	None	$186
2019	4	8	None	$143

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Sort by

Payments by company

Hologic Sales and Service	Aptima	$25	1 payment Meals for Aptima · 2024-08-13 · $25

See the published payment

Sort by

Every published payment

Hologic Sales and Service	Meals · 2024-08-13	Aptima	$25

See earlier years (2021, 2020, 2019)

2021: $22

Sort by

Payments by company in 2021

AbbVie	Lo Loestrin Fe	$22	1 payment Meals for Lo Loestrin Fe · 2021-02-12 · $22

2020: $186

Sort by

Payments by company in 2020

AbbVie	Orilissa	$186	4 payments Meals for Oriahnn · 2020-09-16 · $23 Meals for Orilissa · 2020-06-23 · $19 Meals for Orilissa · 2020-03-12 · $24 Meals for Orilissa · 2020-02-20 · $121

2019: $143

Sort by

Payments by company in 2019

AbbVie	Orilissa	$84	4 payments Meals for Orilissa · 2019-09-16 · $24 Meals for Orilissa · 2019-09-10 · $22 Meals for Orilissa · 2019-08-27 · $18 Meals for Orilissa · 2019-06-21 · $20
Allergan	Lo Loestrin Fe	$29	2 payments Meals for Lo Loestrin Fe · 2019-04-11 · $13 Meals for Lo Loestrin Fe · 2019-01-25 · $16
Exeltis USA	Slynd	$19	1 payment Meals for Slynd · 2019-10-29 · $19
Avion Pharmaceuticals	Balcoltra	$11	1 payment Meals for Balcoltra · 2019-02-04 · $11

Professional record

NPI: 1467412072
Licence: CA A42240California A42240: Current · expires 2027-06-30

More record details

Sole proprietor: No
Taxonomy: Federal specialty code 207V00000X (207V00000X)
Mailing address: 15151 National Ave, Los Gatos, CA, 95032
NPI first listed: 2006-03-27
NPI last updated: 2007-07-08

This is when the NPI record was last certified, not a medical board exam.